CEREBROSPINAL FLUID OXIDATIVE STRESS DURING CHEMOTHERAPY OF ACUTE LYMPHOBLASTIC LEUKEMIA IN CHILDREN

REFERENCES

• Rivera GK, Pinkel D, Simone JV, Treatment of acute lymphoblastic leukemia: 30 years of experience at St. Jude Children's Research Hospital. N Engl J Med. 1993;329:1289–1295.
   PubMed Web of Science ®Google Scholar
• Pui CH, Robison LL, Look AT. Acute lymphoblastic leukaemia. Lancet. 2008;371:1030–1043.
   PubMed Web of Science ®Google Scholar
• Hallbook H, Gustafsson G, Smedmyr B, Treatment outcome in young adults and children >10 years of age with acute lymphoblastic leukemia in Sweden: a comparison between a pediatric protocol and an adult protocol. Cancer. 2006;107:1551–1561.
   PubMed Web of Science ®Google Scholar
• Kingma A, van Dommelen RI, Mooyaart EL, Slight cognitive impairment and magnetic resonance imaging abnormalities but normal school levels in children treated for acute lymphoblastic leukemia with chemotherapy only. J Pediatr. 2001;139:413–420.
   PubMed Web of Science ®Google Scholar
• Iuvone L, Mariotti P, Colosimo C, Long-term cognitive outcome, brain computed tomography scan, and magnetic resonance imaging in children cured for acute lymphoblastic leukemia. Cancer. 2002;95:2562–2570.
   PubMed Web of Science ®Google Scholar
• Glover DA, Byrne J, Mills JL, Impact of CNS treatment on mood in adult survivors of childhood leukemia: a report from the Children's Cancer Group. J Clin Oncol. 2003;21:4395–4401.
   PubMed Web of Science ®Google Scholar
• Hill JM, Kornblith AB, Jones D, A comparative study of the long term psychosocial functioning of childhood acute lymphoblastic leukemia survivors treated by intrathecal methotrexate with or without cranial radiation. Cancer. 1998;82:208–218.
   PubMed Web of Science ®Google Scholar
• Cole PD, Kamen BA. Delayed neurotoxicity associated with therapy for children with acute lymphoblastic leukemia. Ment Retard Dev Disabil Res Rev. 2006;12:174–183.
   PubMedGoogle Scholar
• Møller P, Risom L, Lundby C, Hypoxia and oxidation levels of DNA and lipids in humans and animal experimental models. IUBMB Life. 2008;60:707–723.
   PubMed Web of Science ®Google Scholar
• Valko M, Rhodes CJ, Moncola J, Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact. 2006;160:1–40.
   PubMed Web of Science ®Google Scholar
• Masutani H. Oxidative stress response and signaling in hematological malignancies and HIV infection. Int J Hematol. 2000;71:25–32.
   PubMed Web of Science ®Google Scholar
• Manoharan S, Kalanjiappan K, Kayalvizhi M. Enhanced lipid peroxidation and impaired enzymic antioxidant activities in the erythrocytes of patients with cervical carcinoma. Cell Mol Biol Lett. 2004;9:699–707.
   PubMed Web of Science ®Google Scholar
• Battisti V, Maders LD, Bagatini MD, Measurement of oxidative stress and antioxidant status in acute lymphoblastic leukemia patients. Clin Biochem. 2008;41:511–518.
   PubMed Web of Science ®Google Scholar
• Mazor D, Abucoider A, Meyerstein N, Antioxidant status in pediatric acute lymphocytic leukemia (ALL) and solid tumors: the impact of oxidative stress. Pediatr Blood Cancer. 2008;51:613–615.
   PubMed Web of Science ®Google Scholar
• Surtees R, Clelland J, Heales S. Cerebrospinal fluid concentrations of nitrate plus nitrite during the treatment of acute lymphoblastic leukaemia in childhood. Leuk Res. 1998;22:751–754.
   Google Scholar
• Al-Gayyar MM, Eissa LA, Rabie AM, El-Gayar AM. Measurements of oxidative stress status and antioxidant activity in chronic leukaemia patients. J Pharm Pharmacol. 2007;59:409–417.
   PubMed Web of Science ®Google Scholar
• Quinn CT, Griener JC, Bottiglieri T, Elevation of homocysteine and excitatory amino acid neurotransmitters in the CSF of children who receive methotrexate for the treatment of cancer. J Clin Oncol. 1997;15:2800–2806.
   PubMed Web of Science ®Google Scholar
• Rajamani R, Muthuvel A, Senthilvelan M, Oxidative stress induced by methotrexate alone and in the presence of methanol in discrete regions of the rodent brain, retina and optic nerve. Toxicol Lett. 2006;165:265–273.
   PubMed Web of Science ®Google Scholar
• Vezmar S, Schüsseler P, Becker A, Methotrexate-associated alterations of the folate and methyl-transfer pathway in the CSF of ALL patients with and without symptoms of neurotoxicity. Pediatr Blood Cancer. 2009;52:26–32.
   Google Scholar
• Zhou Y, Hileman EO, Plunkett W, Free radical stress in chronic lymphocytic leukemia cells and its role in cellular sensitivity to ROS-generating anticancer agents. Blood. 2003;101:4098–4104.
   PubMed Web of Science ®Google Scholar
• Van Gool SW, De Meyer G, Van de Voorde A, Neurotoxicity marker profiles in the CSF are not age-dependent but show variation in children treated for acute lymphoblastic leukemia. Neurotoxicology. 2004;25:471–480.
   Google Scholar
• Osterlundh G, Kjellmer I, Lannering B, Neurochemical markers of brain damage in cerebrospinal fluid during induction treatment of acute lymphoblastic leukemia in children. Pediatr Blood Cancer. 2008;50:793–798.
   PubMedGoogle Scholar
• Cole PD, Beckwith KA, Vijayanathan V, Folate homeostasis in cerebrospinal fluid during therapy for acute lymphoblastic leukemia. Pediatr Neurol. 2009;40:34–41.
   PubMed Web of Science ®Google Scholar